Member Info for Bella6532

Thanks Mr. A...that makes far more sense...
So, based on what you say, this does seem to confirm the delay was due to buffer supply as mentioned by Ophidian.
Bioserve UK have already indicated they had a large shipment which has already been allocated and they don't expect the next one until 16 August which is still 10 days away...I wonder if the buffer supply is still an issue?
If anyone orders/receives a box or two after 16 August it would be good to see both the test kit and box Lot details as this should be a good indicator as to whether or not it's the buffer or not.
Let's hope the new owners of Mologic can apply some pressure...

Confidentials...is the single LFT in the picture from your 2nd box because its LOT and date don't match the box in the picture...

Question....if the UK Govt has decided our test is going to be used purely for schools/colleges/unis, how many test will they require per week?

https://www.nationalgeographic.com/animals/article/wild-us-deer-found-with-coronavirus-antibodies

Published in 2019 and shows affimers can be used to diagnose plant viruses...so many potential uses...
https://www.nature.com/articles/s41598-019-43945-6

MrA...haha...perhaps some tweek is what somebody on here needs right now.

This phone is driving me nuts...should read tweek, tweek and tweek again...sorry...

When you are doing R&D work and evaluations on new products its quite normal to tweet, tweet and tweet again between evaluations...
I do believe that it what was meant.
An independent laboratory...not connected to Avacta ran the tests/evaluations.
Avacta sent them samples, the latter sample may have been tweeted by Avacta to see if they could get a better outcome. THIS IS NORMAL....it is not cooking the books or trying to make something look better than it is..it is trying to improve the products overall performance...
Geez...we had hundreds of tests and evaluations run on products for NASA...some done by us others by them some by the supplier of certain raw materials and even some done in specialist Independent facilities.

Jailbird...I live in France...Brexit was best thing to finally highlight rotten aspects of the EU project. Many locals have no problem with Brexit and can't wait for their exit day too...
It's only the expats with holiday homes in the main who are left moaning...the rest of us are happily getting on with our lives and have put Brexit to bed for good...end of.

Interesting RNS...they could have tacked on other news/updates too...but didn't.
So either
A) there is absolutely nothing else they can report on
Or
B) negotiations with whoever prevent such updates.

This RNS tells us nothing that we didn't already know or was being imparted by Calibre anyway.

The play on made in the UK, UK tech etc might be a message but until we get a contract for exactly these reasons its just fluff right now...

Nothing on Mologic and new ownership..nothing to reassure us the new owners are a good thing and we won't be affected adversely by the change.

Nothing on first dosing...

For me it's what they don't say is more telling/informative...hands tied....

'Civil servant who lost MoD files at a bus stop was to be UK’s ambassador to Nato...'
Says it all really...

Bigger you are so wrong...that's not how it works...they will never discuss a distributors accounts/ sales volumes.
Any RNSs will have to contain news bigger than already mentions on a financial prospects basis and we already have some potentially huge deals already. Then there's non disclose agreements...confidentiality clauses etc etc...
If they are in the process of putting deals together we will hear about them once they have been signed off if they are materially big enough.

A major distributor will be talking truckloads...it looks to me like they've taken the orders ahead of receiving their first shipment(s) and if the orders are on an upfront payment basis or 30 day account then they're rolling their purchases over nicely. They may also be having orders shipped direct to large accounts too.
Don't under-estimate the sort of turnover a good large distributor can muster. Also Avacta have said they will be servicing large house accounts themselves too...

Yes...that's what their morning round up is all about.
It's a good morning catch up on what's going on out there...

Sorry..here's the link...is it a reporters assumption or fact because Mologic distributing out tests in low and middle income countries was not mentioned in the Avacta RNS...

https://www.360dx.com/infectious-disease/avacta-mologic-partner-coronavirus-antigen-tests

'Mologic has also agreed to distribute Avacta's SARS-CoV-2 spike antigen test in undisclosed low- and middle-income countries, as well as to provide Avacta with additional test manufacturing capacity.'

Brokestt...the heading was:

'Covid – US and China may be losing control of the Delta variant '

And it's from S P Angels morning round up.

This pandemic is nowhere near over and the next variant is only just around the corner....

• In the US, we hear that slow reporting of new Covid cases is effectively under-reporting the spread and severity of the new Delta Variant.
• Vaccinated people are said to be showing similar viral load as unvaccinated but with much less severe symptoms.
• The Delta variant appears to generate a higher viral load than the original variant increasing cases from outdoor transmission.
• In China, millions of people are under Lockdown as the authorities battle to control the spread of the Delta variant.
• The new variant is reported to have spread to more than 30 cities (Washington Post)
• Nanjing and Zhuzhou cities are under lockdown with smaller specific areas locked down in other areas
• Authorities are to test all 12m residents in Wuhan following reports of three new Delta cases.
• Beijing has cut all travel from areas with Covid cases and only essential travellers are allowed to enter the city.
• China reported 90 new confirmed cases on Tuesday but local reports suggest many more cases are being identified.
• Jiangsu reported 34 patients with symptoms with 5 in Nanjing and 40 in Yangzhou City (Reuters).

'The use of Affimers as detection molecules also provides additional benefits due to their low production cost and consistent batch uniformity. In our hands, these tests present 100% specificity for CCHFV NP and their LOD is 15 ng of recombinant CCHFV NP/strip. There are no previous studies describing the LOD needed for LFA devices to successfully detect CCHFV NP in acute patient samples, nor reference antigen preparation standards for hemorrhagic fever viral NPs [34]. But different types of point-of-care diagnostic tests have shown the ability to detect hemorrhagic fever viral NPs in virus isolates and patient samples, such is the case for Lassa virus [35], Ebola virus [36] or RVFV [37]. In order to determine if the sensitivity of our current device is sufficient to detect CCHFV NP in real patient samples, it will need to be experimentally tested and optimized using patient samples under high-level biosafety containment. Nonetheless, the results presented in this study serve as proof of concept for the use of Affimers in LFAs and represent the first prototype point-of-care diagnostic test for the detection of recombinant CCHFV NP in sera described to date. These findings represent a possible starting point for the future development of Affimer-based diagnostic assays for the detection of CCHFV NP, contributing to the preparedness for potential future outbreak scenarios.'

Published 2020
'Characterization and applications of a Crimean-Congo hemorrhagic fever virus nucleoprotein-specific Affimer: Inhibitory effects in viral replication and development of colorimetric diagnostic tests'

No reference to Avacta...but reference to GE Healthcare and Porton Down and its a cheap LFT that works especially in out if the way places...

Is this the sort if thing Avacta is going to be assisting Mologic with...